Edition:
United Kingdom

Avinger Inc (AVGR.OQ)

AVGR.OQ on NASDAQ Stock Exchange Capital Market

1.40USD
19 Sep 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.40
Open
$1.40
Day's High
$1.40
Day's Low
$1.40
Volume
1,609
Avg. Vol
174,920
52-wk High
$25.16
52-wk Low
$0.95

Latest Key Developments (Source: Significant Developments)

Avinger Receives FDA Clearance Of Next Generation Pantheris Device
Wednesday, 23 May 2018 

May 23 (Reuters) - Avinger Inc ::AVINGER RECEIVES FDA CLEARANCE OF NEXT GENERATION PANTHERIS DEVICE.AVINGER - DISTRIBUTION OF PANTHERIS WILL BE EXPANDED AS CO INCREASES PRODUCTION AND GAINS PURCHASING APPROVALS IN ADDITIONAL LUMIVASCULAR SITES.  Full Article

Avinger Inc Files For Common Stock Offering Of Up To $15 Mln
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Avinger Inc ::AVINGER INC FILES FOR COMMON STOCK OFFERING OF UP TO $15.0 MILLION - SEC FILING.  Full Article

Avinger Says Executive Chairman John Simpson Will Be Leaving Company
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Avinger Inc ::AVINGER ANNOUNCES CHANGE IN BOARD LEADERSHIP.AVINGER INC - JOHN B. SIMPSON, FOUNDER AND EXECUTIVE CHAIRMAN OF AVINGER, WILL BE LEAVING COMPANY.AVINGER INC - CONCURRENT WITH SIMPSON'S DEPARTURE, JAMES G. CULLEN HAS BEEN APPOINTED NON-EXECUTIVE CHAIRMAN OF BOARD.  Full Article

Avinger Q3 loss per share $0.43
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Avinger Inc ::Avinger announces third quarter 2017 results.Q3 loss per share $0.43.Q3 revenue fell 61 percent to $2.1 million.Avinger Inc - ‍cash and cash equivalents totaled $10.2 million as of Sept 30, 2017, compared to $14.0 million as of June 30, 2017​.  Full Article

Avinger says it entered into purchase agreement, registration rights agreement
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Avinger Inc ::Co entered into purchase agreement, registration rights agreement for up to $15.0 million worth of stock, $0.001 par value per share​.  Full Article

Avinger says ‍received 510(k) clearance from U.S. FDA for modifications to co's pantheris lumivascular atherectomy system​
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Avinger Inc :Avinger Inc says ‍received 510(k) clearance from U.S. FDA for modifications to co's pantheris lumivascular atherectomy system​.  Full Article